238 related articles for article (PubMed ID: 26414077)
1. Middle East respiratory syndrome: current status and future prospects for vaccine development.
Du L; Jiang S
Expert Opin Biol Ther; 2015; 15(11):1647-51. PubMed ID: 26414077
[TBL] [Abstract][Full Text] [Related]
2. Receptor-binding domain-based subunit vaccines against MERS-CoV.
Zhang N; Tang J; Lu L; Jiang S; Du L
Virus Res; 2015 Apr; 202():151-9. PubMed ID: 25445336
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
4. Prospects for a MERS-CoV spike vaccine.
Zhou Y; Jiang S; Du L
Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
[TBL] [Abstract][Full Text] [Related]
5. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
[TBL] [Abstract][Full Text] [Related]
6. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
Cho H; Excler JL; Kim JH; Yoon IK
Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
[TBL] [Abstract][Full Text] [Related]
7. An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies.
Zhang N; Shang J; Li C; Zhou K; Du L
Expert Rev Vaccines; 2020 Sep; 19(9):817-829. PubMed ID: 32842811
[TBL] [Abstract][Full Text] [Related]
8. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
[TBL] [Abstract][Full Text] [Related]
9. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
[TBL] [Abstract][Full Text] [Related]
10. Vaccines for the prevention against the threat of MERS-CoV.
Du L; Tai W; Zhou Y; Jiang S
Expert Rev Vaccines; 2016 Sep; 15(9):1123-34. PubMed ID: 26985862
[TBL] [Abstract][Full Text] [Related]
11. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
[TBL] [Abstract][Full Text] [Related]
12. [Novel Research Progress of the Recombinant Vaccine for MERS-CoV].
Hu H; Shen Y
Bing Du Xue Bao; 2016 Jul; 32(4):495-500. PubMed ID: 29995374
[TBL] [Abstract][Full Text] [Related]
13. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
14. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
[TBL] [Abstract][Full Text] [Related]
15. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.
Chi H; Zheng X; Wang X; Wang C; Wang H; Gai W; Perlman S; Yang S; Zhao J; Xia X
Vaccine; 2017 Apr; 35(16):2069-2075. PubMed ID: 28314561
[TBL] [Abstract][Full Text] [Related]
18. [Current Status of Middle East Respiratory Syndrome Vaccines].
Fan Y; Jiang Z; Li P; Den Y; Huang J; Zhu L; Xu Z
Bing Du Xue Bao; 2016 Nov; 32(6):825-9. PubMed ID: 30004658
[TBL] [Abstract][Full Text] [Related]
19. Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen.
Nyon MP; Du L; Tseng CK; Seid CA; Pollet J; Naceanceno KS; Agrawal A; Algaissi A; Peng BH; Tai W; Jiang S; Bottazzi ME; Strych U; Hotez PJ
Vaccine; 2018 Mar; 36(14):1853-1862. PubMed ID: 29496347
[TBL] [Abstract][Full Text] [Related]
20. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
